Table 1.
Study | Protocol | Definition | Incidence |
---|---|---|---|
Silverberg et al., 1991 | GnRHa | P > 0.9 ng/mL | 12.4% |
Martinez et al., 2004 | GnRHa | P > 0.9 ng/mL | 52.3% |
Edelstein et al. 1990; Silverberg et al. 1991, Fanchin et al. 1993; Givens et al. 1994; Harada et al. 1995; Ubaldi et al. 1995, 1996 | GnRHa | P > .8–2 ng/mL | 5–35% |
Younis et al. 2001; Ou et al. 2007 | GnRHa | P/E2 > 1 | 41% |
Ubaldi et al. 1996 | GnRH antagonist | P > 1.1 ng/mL | 20% |
Bosch et al. 2003 | GnRH antagonist | P > 1.2 ng/mL | 38.3% |
Sims et al. 1994 | Flare up | P > 1.0 ng/ml | 85% |